Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Management of Atypical Liver Nodules

Diagnostic Approach

  • For atypical liver nodules, biopsy is recommended when imaging studies fail to provide a definitive diagnosis, especially if the nodule shows growth or changes in enhancement pattern during follow-up, according to the European Association for the Study of the Liver 1
  • The American Association for the Study of Liver Diseases recommends follow-up with imaging every 3-4 months during the first year for nodules <1 cm 2, 1
  • If stable for 12 months, return to regular six-month surveillance, as suggested by the European Association for the Study of the Liver 1, 3
  • For nodules 1-2 cm, perform multiphasic contrast-enhanced CT or MRI with extracellular contrast agents or gadoxetic acid, as recommended by the European Association for the Study of the Liver 1
  • If imaging shows typical HCC hallmarks, diagnose as HCC, according to the American Association for the Study of Liver Diseases 2, 1

Biopsy Considerations

  • Biopsy is indicated when imaging findings are inconclusive or atypical, with a sensitivity ranging between 70-90% depending on location, size, and expertise, as reported by the European Association for the Study of the Liver 2, 1
  • Biopsy challenges include false negative results, especially in small nodules, and a risk of tumor seeding of approximately 2.7%, as noted by the European Association for the Study of the Liver 4

Pathological Diagnosis

  • Core needle biopsy is recommended over fine needle aspiration for early HCC or dysplastic nodule diagnosis, according to the Asian Pacific Association for the Study of the Liver 5
  • Consider immunohistochemical markers, such as a panel of HSP70, GPC3, and glutamine synthetase, to improve diagnostic accuracy, with a sensitivity and specificity for diagnosing early HCC of 60% and 100%, respectively, as reported by the European Association for the Study of the Liver 4

Follow-up and Special Considerations

  • Continue imaging surveillance every 3-4 months after inconclusive biopsy, as recommended by the American Association for the Study of Liver Diseases 2, 1
  • Atypical nodules in non-cirrhotic livers should always undergo pathological diagnosis, according to the European Association for the Study of the Liver 4
  • Multidisciplinary team discussion is recommended for complex cases, as suggested by the European Association for the Study of the Liver 1